跳至主要内容
临床试验/CTRI/2022/01/039728
CTRI/2022/01/039728进行中(未招募)2 期

The Clinical study to evaluate the Rasayana effect of Bharangi Guda IN Post COVID subjects

DR ROOPA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • postcovid subject with signs and symptoms of fatigue dyspnoea disturbed sleep cough anorexia and weight loss
  • haemoglobin greater than 8gm/dl
  • upto 1year subjects will be considered for study once he diagnosed as covid19 positive
  • during trial sobjects PTPCR report must be negative
  • subjects who are vaccinated eith 1stdose or both the doses
  • subjects must have either RT[CR or RAT reports positve to claim that they have exposed to SARS CoV 2 virus

排除标准

  • Patient having history of Diabetes mellitus
  • Other Systemic diseases like Sexual transmitted diseases Acquired immuno deficiency virus etc
  • Other postcovid complications like Mucormycosis
  • Pregnant and lactating mothers are excluded from the study

研究者

发起方
DR ROOPA

相似试验